Friday, 30 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Latest announcements

Every corporate announcement our alert engine sent, newest first: orders, results, earnings calls, fund raises, board meetings and more.

18:20 IST NSE
Other AnnouncementCrizac Ltd CRIZAC

Crizac Other Announcement

Crizac Limited submitted its quarterly compliance certificate under SEBI Regulations for the period ended March 31, 2026. The registrar, MUFG Intime India, confirmed no requests for dematerialization or rematerialization of shares were received during the quarter. This is a routine regulatory disclosure with no material impact on company operations.

Execution
Quarter ended March 31, 2026
18:18 IST NSE
Regulatory ApprovalAurobindo Pharma Ltd AUROPHARMA

Aurobindo Pharma Regulatory Approval

Aurobindo Pharma received USFDA approval for Dapagliflozin and Metformin Hydrochloride ER Tablets, targeting a US$ 514 Million (₹4,780.2 Crore) market. The product, bioequivalent to AstraZeneca's Xigduo XR, will be manufactured at APL Healthcare's Unit-IV and launched immediately with 180 days of shared exclusivity.

Value
₹4,780 Cr
18:17 IST BSE
Other AnnouncementEraaya Lifespaces Ltd EBIX

Eraaya Lifespaces Other Announcement

Eraaya Lifespaces Limited submitted its Reconciliation of Share Capital Audit Report for the quarter ended March 31, 2026. The report confirms a total issued capital of 20,66,94,160 shares, including the conversion of 74,10,000 warrants into equity during the period. No discrepancies were found between the issued, listed, and dematerialized capital.

18:17 IST NSE
Other AnnouncementFineotex Chemical Ltd FCL

Fineotex Chemical Other Announcement

Fineotex Chemical Limited submitted its quarterly compliance certificate under SEBI (Depositories and Participants) Regulations, 2018 for the period ended March 31, 2026. The Registrar, Bigshare Services, confirmed that security certificates received for dematerialization were processed and listed on the exchanges within the stipulated 15-day timeline.

Execution
quarter ended March 31, 2026
18:17 IST BSE
Other AnnouncementBharat Agri Fert & Realty Ltd BHARATAGRI

Bharat Agri Fert & Realty Other Announcement

Bharat Agri Fert & Realty Ltd submitted its quarterly compliance certificate under SEBI (Depositories and Participants) Regulations for the period ended March 31, 2026. The Registrar and Transfer Agent, MUFG Intime India, confirmed the processing of dematerialisation requests within prescribed timelines. This is a routine administrative filing with no material financial impact.

18:15 IST BSE
New Order WinRDB Infrastructure and Power Ltd RDBRIL

RDB Infrastructure and Power Bags ₹36.9 Cr Order

RDB Infrastructure and Power, in consortium with Samvik Power, received a Rs. 36.90 Crore award for an industrial plot in Nava Raipur, Chhattisgarh. The 36.45-acre site is allotted on a 90-year lease for solar cell manufacturing and processing. This strategic allotment marks the company's expansion into renewable energy infrastructure.

Value
₹36.90 Cr
Execution
90 years (leasehold basis)
18:14 IST NSE
Regulatory ApprovalAurobindo Pharma Ltd AUROPHARMA

Aurobindo Pharma Regulatory Approval

Aurobindo Pharma received USFDA approval for Dapagliflozin Tablets (5 mg and 10 mg), addressing a US$ 10.2 billion market. The product, bioequivalent to Farxiga, will be manufactured at APL Healthcare's Unit-IV and launched immediately with 180 days of shared generic exclusivity.

Value
₹94,860 Cr